latest news releases from the newsroom
Execute Sports, Inc.
Execute Sports Sales Hit All-Time Highs
TORRANCE, Calif., July 9, 2007 (PRIME NEWSWIRE) -- Execute Sports Inc. (OTCBB:EXCS) today announced that it has just completed its largest sales quarter in the history of the company. Sales for the second quarter exceeded $800K, representing a 77% increase of same product sales over Q2 '06.
The Children's Place, Inc.
The Children's Place Retail Stores, Inc. Comments On June Sales, Second Quarter Outlook
SECAUCUS, N.J., July 9, 2007 (PRIME NEWSWIRE) -- The Children's Place Retail Stores, Inc. (Nasdaq:PLCE) today announced total consolidated sales of approximately $154.7 million for the five-week period ended July 7 2007, an approximate 2% increase compared to sales of $151.7 million for the five-week period ended July 1, 2006. Consolidated comparable store sales decreased approximately 4% for the five weeks ended July 7, 2007, compared to a 15% increase last year. Consolidated June comparable store sales are comprised of an approximate 4% decrease at The Children's Place brand, and an approximate 3% decrease at Disney Store. Quarter-to-date, consolidated comparable store sales are approximately flat compared to last year's 14% increase. Final June sales results will be reported on Wednesday, July 11, 2007, before the market opens.
Genesis Pharmaceuticals Enterprises, Inc.
Genesis Announces Chinese Client Completes Public Merger
BEIJING, July 9, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc (OTCBB:GTEC) today confirmed that Gold Horse International, Inc. (OTCBB:SPEH) is a public company, trading on the Over-The-Counter Bulletin Board. Having successfully completed an acquisition by Speedhaul Holdings, Inc., Gold Horse became the second partner company to complete the new Genesis private-to-public program.
Karin Ludwig, M.D. Joins Alacrity Biosciences as Chief Medical Officer
LAGUNA HILLS, Calif., July 9, 2007 (PRIME NEWSWIRE) -- Alacrity Biosciences, Inc., (Alacrity) a biopharmaceutical company focused on meeting unmet needs in ophthalmic diseases, announced that Karin Ludwig, M.D. has joined the company as its Chief Medical Officer. Dr. Ludwig brings more than 16 years of medical and drug development experience, including ophthalmics, to the company. Dr. Ludwig comes to Alacrity from her most recent position as Senior Vice President, Clinical Research at Amicus Therapeutics in Cranbury, NJ.